Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
The current Ionis Pharmaceuticals(IONS) stock price is $78.51, with a market capitalization of 12.97B. The stock trades at a price-to-earnings (P/E) ratio of -31.89.
On 2026-03-04, Ionis Pharmaceuticals(IONS) stock traded between a low of $77.67 and a high of $79.27. Shares are currently priced at $78.51, which is +1.1% above the low and -1.0% below the high.
The Ionis Pharmaceuticals(IONS)'s current trading volume is 1.07M, compared to an average daily volume of 2.54M.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $23.95 at its lowest and $86.74 at its peak.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $23.95 at its lowest and $86.74 at its peak.
IONS News
...
Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA Priority Review for olezarsen in severe hypertriglyceridemia, indicating an expedited regulatory timeline. N...
Piper Sandler analyst Allison Bratzel raised the firm’s price target on Ionis Pharmaceuticals (IONS) to $100 from $87 and keeps an Overweight rating on the shar...
Analyst ratings
74%
of 23 ratingsMore IONS News
Advertisement Ionis Pharmaceuticals overview and recent share performance Ionis Pharmaceuticals (IONS) has drawn investor attention recently, with the share p...
Ionis Pharmaceuticals Inc. ((IONS)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund...
Analyst Yaron Werber of TD Cowen maintained a Buy rating on Ionis Pharmaceuticals, boosting the price target to $110.00. Yaron Werber has given his Buy rating...
In a report released today, Joseph Stringer from Needham maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $103.00. Joseph Stringer has...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.